Old Web
English
Sign In
Acemap
>
Paper
>
386PTP53 GOF mutations predict good response and prolonged survival to bevacizumab treatment in metastatic colorectal cancer
386PTP53 GOF mutations predict good response and prolonged survival to bevacizumab treatment in metastatic colorectal cancer
2018
Y.L. Hsieh
Y T Liu
N Lapke
H-C Hsu
H-C. Chen
S.J. Chen
K. T. Tan
Keywords:
General surgery
Bevacizumab
Medicine
Colorectal cancer
Pathology
Internal medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]